Insulet Funding & Investors
Insulet Corporation operates as a medical device company. The Company develops, manufactures, and markets an insulin infusion system for people with insulin-dependent diabetes. Insulet markets its products in the United Kingdom, Canada, and United States.
insulet.comTotal Amount Raised: $179,500,000
Insulet Funding Rounds
Post Ipo Debt
$60,000,000
Post Ipo Debt Investors
Deerfield ManagementSeries E
$50,000,000
Series E Investors
OrbiMed AdvisorsAlta PartnersFederated Kaufmann FundPequot CapitalVersant VenturesSchroder VenturesPrism Venture ManagementSeries D
$35,500,000
Series D Investors
Alta PartnersMedVenture AssociatesTIAAPiper JaffrayVersant VenturesSV Health InvestorsOakwood Medical InvestorsPrism Venture ManagementPequot CapitalSeries C
$22,000,000
Series C Investors
Oakwood Medical InvestorsPrism Venture ManagementSV Health InvestorsVersant VenturesSeries B
$11,000,000
Series B Investors
Schroder VenturesVersant VenturesPrism Venture ManagementSeries A
$1,000,000
Series A Investors
Prism Venture Management
Funding info provided by Diffbot.